Holger Thiele

Showing 1-19 of 19 articles

TAVI and horizontal aorta: a "no impact" relationship?

Abdel-Wahab M, Kitamura M, Thiele H

October 4, 2019 | 10.4244/EIJV15I9A136

Reply to the letter to the editor "The impact of chronic total occlusion in non-infarct-related coronary arteries"

Saad M, Fuernau G, Eitel I, Thiele H

June 12, 2019 | 10.4244/EIJ-D-18-00787R

Interventions for valvular disease

Transcatheter treatment of tricuspid regurgitation using edge-to-edge repair: procedural results, clinical implications and predictors of success

Lurz P, Besler C, Noack T, Forner AF, Bevilacqua C, Seeburger J, Rommel K-P, Blazek S, Hartung P, Zimmer M, Mohr F, Schuler G, Linke A, Ender J, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-01091

Prognostic impact of non-culprit chronic total occlusions in infarct-related cardiogenic shock: results of the randomised IABP-SHOCK II trial

Saad M, Fuernau G, Desch S, Eitel I, de Waha S, Poss J, Ouarrak T, Schneider S, Zeymer U, Thiele H

June 14, 2018 | 10.4244/EIJ-D-17-00451

Mechanical circulatory support: the last resort in cardiogenic shock?

Thiele H, Desch S, de Waha S

April 6, 2018 | 10.4244/EIJV13I18A344

Coronary interventions

ADP receptor antagonists in patients with acute myocardial infarction complicated by cardiogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis

Orban M, Limbourg T, Neumann F, Ferenc M, Olbrich H-G, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Poss J, Schneider S, Schuler G, Werdan K, Zeymer U, Thiele H, Hausleiter J

December 9, 2016 | 10.4244/EIJY15M12_04

Percutaneous left ventricular assist devices

Thiele H, Fuernau G, Fischer J, Schuler G

November 16, 2016

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort

de Waha S, Fuernau G, Eitel I, Desch S, Thiele H

June 20, 2016 | 10.4244/EIJV12I3A71

Interventions for heart failure

Percutaneous ventricular assist devices and extracorporeal life support: current applications

Blumenstein J, de Waha S, Thiele H

May 16, 2016 | 10.4244/EIJV12SXA12

Interventions for valvular disease

Interventional post-myocardial infarction ventricular septal defect closure: a systematic review of current evidence

Schlotter F, de Waha S, Eitel I, Desch S, Fuernau G, Thiele H

May 16, 2016 | 10.4244/EIJV12I1A17

Coronary interventions

How should I treat a massive left main coronary artery thrombosis in a 49-year-old woman in the context of cardiogenic shock?

Marchese A, Paradies V, Basile M, Iorio E, Palmiotto A, Fiore F, Musumeci G, de Waha S, Thiele H, Wan S, Yaku H

April 8, 2016 | 10.4244/EIJV11I14A321

Interventions for heart failure

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

de Waha S, Fuernau G, Desch S, Eitel I, Wiedau A, Lurz P, Schuler G, Thiele H

March 18, 2016 | 10.4244/EIJV11I12A265

Incidence, predictors, and treatment options of critical limb ischaemia after use of collagen plug-based vascular closure devices

Amer O, Binger S, Desch S, Harnoss H, Schuler G, Thiele H, Eitel I

November 20, 2015 | 10.4244/EIJV11I7A166

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

Zeymer U, Hochadel M, Thiele H, Andresen D, Schühlen H, Brachmann J, Elsasser A, Gitt A, Zahn R

July 20, 2015 | 10.4244/EIJY14M08_04

Incidence, characteristics and functional implications of cerebral embolic lesions after the MitraClip procedure

Blazek S, Lurz P, Mangner N, Fuernau G, Seeburger J, Luecke C, Gutberlet M, Ender J, Desch S, Eitel I, Schuler G, Thiele H

February 20, 2015 | 10.4244/EIJY14M05_10

Shock management in acute myocardial infarction

Poss J, Desch S, Thiele H

August 19, 2014 | 10.4244/EIJV10STA12

Intracoronary versus intravenous bolus abciximab administration in patients undergoing primary percutaneous coronary intervention with acute ST-elevation myocardial infarction: a pooled analysis of individual patient data from five randomised controlled trials

Piccolo R, Eitel I, Iversen A, Gu Y, Dominguez-Rodriguez A, de Smet B, Mahmoud K, Abreu-Gonzalez P, Thiele H, Piscione F

January 20, 2014

Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial

Heeger C-H, Jaquet K, Thiele H, Zulkarnaen Y, Cuneo A, Haller D, Kivelitz D, Schmidt T, Krause K, Metzner A, Schneider C, Kuck K, Bergmann M

October 26, 2012 | 10.4244/EIJV8I6A113

Tools & Techniques: Percutaneous left ventricular assist devices

Thiele H, Fürnau G, Fischer J, Schuler G

September 30, 2011 | 10.4244/EIJV7I5A101

1

Latest news

"Shocktopics” with intravascular lithotripsy, bioprosthetic valve fracture, myocardial fibrosis in TAVI...

Reimaged models and angiograms showing CO March 17, 2020

New ahead of print: Infolding of self expanding valve during transcatheter aortic valve implantation

Nandhakumar Vasu et al

Bioresorbable scaffolds and STEMI: an ideal setting, but still vacant

Christian Spaulding

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Defining procedural MI - does it matter (spoiler alert - it does!)

This week’s JAA’s: QFR in severe AS & Infection control for TAVI

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke